152 related articles for article (PubMed ID: 36633901)
1. The majority of 922 prediction models supporting breast cancer decision-making are at high risk of bias.
Hueting TA; van Maaren MC; Hendriks MP; Koffijberg H; Siesling S
J Clin Epidemiol; 2022 Dec; 152():238-247. PubMed ID: 36633901
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Large-scale validation of the prediction model risk of bias assessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination.
Venema E; Wessler BS; Paulus JK; Salah R; Raman G; Leung LY; Koethe BC; Nelson J; Park JG; van Klaveren D; Steyerberg EW; Kent DM
J Clin Epidemiol; 2021 Oct; 138():32-39. PubMed ID: 34175377
[TBL] [Abstract][Full Text] [Related]
4. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
5. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
[TBL] [Abstract][Full Text] [Related]
6. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies.
Wolff RF; Moons KGM; Riley RD; Whiting PF; Westwood M; Collins GS; Reitsma JB; Kleijnen J; Mallett S;
Ann Intern Med; 2019 Jan; 170(1):51-58. PubMed ID: 30596875
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
8. Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST.
Wang S; Huang H; Hou M; Xu Q; Qian W; Tang Y; Li X; Qian G; Ma J; Zheng Y; Shen Y; Lv H
Pediatr Res; 2023 Sep; 94(3):1125-1135. PubMed ID: 36964445
[TBL] [Abstract][Full Text] [Related]
9. Prognostic models for predicting relapse or recurrence of major depressive disorder in adults.
Moriarty AS; Meader N; Snell KI; Riley RD; Paton LW; Chew-Graham CA; Gilbody S; Churchill R; Phillips RS; Ali S; McMillan D
Cochrane Database Syst Rev; 2021 May; 5(5):CD013491. PubMed ID: 33956992
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
11. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal.
Wynants L; Van Calster B; Collins GS; Riley RD; Heinze G; Schuit E; Bonten MMJ; Dahly DL; Damen JAA; Debray TPA; de Jong VMT; De Vos M; Dhiman P; Haller MC; Harhay MO; Henckaerts L; Heus P; Kammer M; Kreuzberger N; Lohmann A; Luijken K; Ma J; Martin GP; McLernon DJ; Andaur Navarro CL; Reitsma JB; Sergeant JC; Shi C; Skoetz N; Smits LJM; Snell KIE; Sperrin M; Spijker R; Steyerberg EW; Takada T; Tzoulaki I; van Kuijk SMJ; van Bussel B; van der Horst ICC; van Royen FS; Verbakel JY; Wallisch C; Wilkinson J; Wolff R; Hooft L; Moons KGM; van Smeden M
BMJ; 2020 Apr; 369():m1328. PubMed ID: 32265220
[TBL] [Abstract][Full Text] [Related]
12. Risk Prediction Models for Cardiotoxicity of Chemotherapy Among Patients With Breast Cancer: A Systematic Review.
Kaboré EG; Macdonald C; Kaboré A; Didier R; Arveux P; Meda N; Boutron-Ruault MC; Guenancia C
JAMA Netw Open; 2023 Feb; 6(2):e230569. PubMed ID: 36821108
[TBL] [Abstract][Full Text] [Related]
13. Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review.
Thurtle D; Rossi SH; Berry B; Pharoah P; Gnanapragasam VJ
BMJ Open; 2019 Jun; 9(6):e029149. PubMed ID: 31230029
[TBL] [Abstract][Full Text] [Related]
14. Appraising prediction research: a guide and meta-review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST).
de Jong Y; Ramspek CL; Zoccali C; Jager KJ; Dekker FW; van Diepen M
Nephrology (Carlton); 2021 Dec; 26(12):939-947. PubMed ID: 34138495
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias.
Corti C; Cobanaj M; Marian F; Dee EC; Lloyd MR; Marcu S; Dombrovschi A; Biondetti GP; Batalini F; Celi LA; Curigliano G
Cancer Treat Rev; 2022 Jul; 108():102410. PubMed ID: 35609495
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of patient-reported outcome measures (PROMs) in adults with non-small cell Lung Cancer: a scoping review.
Liao K; Wang T; Coomber-Moore J; Wong DC; Gomes F; Faivre-Finn C; Sperrin M; Yorke J; van der Veer SN
BMC Cancer; 2022 Oct; 22(1):1076. PubMed ID: 36261794
[TBL] [Abstract][Full Text] [Related]
17. Machine learning models for diabetes management in acute care using electronic medical records: A systematic review.
Kamel Rahimi A; Canfell OJ; Chan W; Sly B; Pole JD; Sullivan C; Shrapnel S
Int J Med Inform; 2022 Apr; 162():104758. PubMed ID: 35398812
[TBL] [Abstract][Full Text] [Related]
18. Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies.
Kaiser I; Mathes S; Pfahlberg AB; Uter W; Berking C; Heppt MV; Steeb T; Diehl K; Gefeller O
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740698
[TBL] [Abstract][Full Text] [Related]
19. Outcome prediction models incorporating clinical variables for Head and Neck Squamous cell Carcinoma: A systematic review of methodological conduct and risk of bias.
Aly F; Hansen CR; Al Mouiee D; Sundaresan P; Haidar A; Vinod S; Holloway L
Radiother Oncol; 2023 Jun; 183():109629. PubMed ID: 36934895
[TBL] [Abstract][Full Text] [Related]
20. Protocol for a systematic review on the methodological and reporting quality of prediction model studies using machine learning techniques.
Andaur Navarro CL; Damen JAAG; Takada T; Nijman SWJ; Dhiman P; Ma J; Collins GS; Bajpai R; Riley RD; Moons KG; Hooft L
BMJ Open; 2020 Nov; 10(11):e038832. PubMed ID: 33177137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
